May 4 2020
Biopharm Dive
https://www.biopharmadive.com/news/gilead-remdesivir-icer-coronavirus-drug-price/577282/
$10 cost recovery price
http://viruseradication.com/journal-details/Minimum_costs_to_manufacture_new_treatments_for_COVID-19/
ICER
https://icer-review.org/announcements/alternative_pricing_models_for_remdesivir/
ICER COVID models
https://icer-review.org/material/icer-covid-models/
##
Endpoints
https://endpts.com/with-the-pricing-ball-in-gileads-court-icer-offers-some-parameters-on-how-it-can-be-played-analyst-sees-at-least-1b-in-theory/
Bloomberg
https://www.bloomberg.com/news/articles/2020-05-04/gilead-could-make-a-profit-from-covid-19-drug-analysts-say
Business Insider
https://www.businessinsider.com/coronavirus-treatment-icer-pricing-analysis-on-gileads-remdesivir-2020-5
Fierce Pharma
https://www.fiercepharma.com/marketing/gilead-s-covid-19-therapy-remdesivir-worth-4-460-per-course-says-pricing-watchdog
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.